Pyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only, Dist. by: VistaPharm, NDC 66689-406-01
Published November 2, 2022 · Recall initiated: September 30, 2022
Summary
FDA records drug Class II recall D-0018-2023, published November 2, 2022 and initiated September 30, 2022. Recalling firm: VistaPharm, Inc.; Status: Terminated; Reported quantity: 1980 cups; Lot: Lot#: 832400, Exp 08/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations: Out of specification for assay of one of the preservative ingredients.
What to do
Voluntary: Firm initiated · Letter
Get an email if PYRIDOSTIGMINE BROMIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PYRIDOSTIGMINE BROMIDE
- Manufacturer
- VistaPharm, Inc.
- Distributor
- USA Nationwide
- Lot
- Lot#: 832400, Exp 08/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAProton Armor, Anti-Microbial Alcohol-Free Foaming Hand Sanitizer, kills 99.99% of germs, Green Tea and Aloe,November 2, 2022
- FDAAtenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by:November 2, 2022
- FDAProton Armor, Anti-Microbial Alcohol-Free Foaming Hand Sanitizer, kills 99.99% of germs, Odor Free, FamilyNovember 2, 2022
- FDAFondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by:November 2, 2022
- FDAQuinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: AurobindoNovember 2, 2022
- FDAMedicina Oral Tip Syringe 2.5ml Code: OT25October 26, 2022
Questions about this recall
Was Pyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only, Dist. by: VistaPharm, NDC 66689-406-01 recalled?
Yes. FDA published recall D-0018-2023 on November 2, 2022. Reported hazard: cGMP Deviations: Out of specification for assay of one of the preservative ingredients.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PYRIDOSTIGMINE BROMIDE.